PATENT CLAIM ANALYSIS

Application Number: 15878877
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["564", "381000"]

Abstract:
The present invention relates to a process for the preparation of selegiline base, an irreversible and selective inhibitor of the MAO-B enzymes and which is used in the treatment of Parkinson's Disease.

Claim (Index 6):
The process according to  claim 3 , wherein the inorganic base is sodium hydroxide.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 86.0
- Lexical Diversity: 1.16667
- Patent Class: 564.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14773397', '12602348', '13263397', '12858779', '16066402']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7242069685112056
- 35 USC 102 Novelty (BERT): 0.4853842755115468
- Combined Prediction Score: 0.7003246992112397
- Mean Citation Score: 177.256078
- Max Citation Score: 185.17592
- Similarity Product: 156.57556550368784

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test